The current valuation score of Alvotech SA is 5.62, ranking 360 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is 42.76, which is 2.91% below the recent high of 44.00 and 136.54% above the recent low of -15.62.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.